JAKAVI 5 MG COM CT BL AL PLAS PVC/PCTFE TRANS X 60
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1006811210019 -
GGREM
526516020085601 -
Código de barras
7896261018624
O que a fonte publica
- Detentor do registro
- NOVARTIS BIOCIENCIAS S.A
- Princípios ativos
- FOSFATO DE RUXOLITINIBE
- Embalagem
- 5 MG COM CT BL AL PLAS PVC/PCTFE TRANS X 60
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Novo
- Classe terapêutica
- L1H7 - ANTINEOPLÁSICOS INIBIDORES DA PROTEÍNA QUINASE, JAK
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "JAKAVI 5 MG COM CT BL AL PLAS PVC/PCTFE TRANS X 60",
"holder": "NOVARTIS BIOCIENCIAS S.A",
"stripe": "Tarja Vermelha",
"barcodes": [
"7896261018624"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "526516020085601",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "56.994.502/0001-30",
"priceRegime": "Regulado",
"productName": "JAKAVI",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "5 MG COM CT BL AL PLAS PVC/PCTFE TRANS X 60",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "15913.79",
"icms-12": "18083.86",
"icms-17": "19173.24",
"icms-18": "19407.06",
"icms-19": "19646.66",
"icms-20": "19892.24",
"icms-21": "20144.04",
"icms-22": "20402.29",
"icms-23": "20667.25",
"icms-17.5": "19289.44",
"icms-19.5": "19768.68",
"icms-20.5": "20017.35",
"icms-22.5": "20533.93",
"icms-12-alc": "16146.31",
"icms-17-alc": "17118.96",
"icms-18-alc": "17327.73",
"icms-19-alc": "17541.64",
"icms-20-alc": "17760.92",
"icms-21-alc": "17985.75",
"icms-22-alc": "18216.32",
"icms-23-alc": "18452.90",
"withoutTaxes": "14208.74",
"icms-17.5-alc": "17222.72",
"icms-19.5-alc": "17650.61",
"icms-20.5-alc": "17872.62",
"icms-22.5-alc": "18333.85"
},
"pisCofinsList": "Negativa",
"substanceText": "FOSFATO DE RUXOLITINIBE",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "21347.78",
"icms-12": "24258.85",
"icms-17": "25720.22",
"icms-18": "26033.88",
"icms-19": "26355.29",
"icms-20": "26684.73",
"icms-21": "27022.51",
"icms-22": "27368.95",
"icms-23": "27724.38",
"icms-17.5": "25876.10",
"icms-19.5": "26518.98",
"icms-20.5": "26852.56",
"icms-22.5": "27545.54",
"icms-12-alc": "22321.33",
"icms-17-alc": "23665.96",
"icms-18-alc": "23954.57",
"icms-19-alc": "24250.29",
"icms-20-alc": "24553.43",
"icms-21-alc": "24864.24",
"icms-22-alc": "25182.99",
"icms-23-alc": "25510.05",
"withoutTaxes": "19642.75",
"icms-17.5-alc": "23809.40",
"icms-19.5-alc": "24400.93",
"icms-20.5-alc": "24707.85",
"icms-22.5-alc": "25345.47"
},
"invalidBarcodes": [],
"activeSubstances": [
"FOSFATO DE RUXOLITINIBE"
],
"therapeuticClass": "L1H7 - ANTINEOPLÁSICOS INIBIDORES DA PROTEÍNA QUINASE, JAK",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1006811210019",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "L1H7",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:526516020085601"